Site icon The Rojak Pot

Malaysia Approves CanSino + J&J COVID-19 Vaccines!

KKM has conditionally approved the CanSino and Johnson & Johnson COVID-19 vaccines for use in Malaysia!

Find out what this means for the COVID-19 vaccination programme in Malaysia!


Malaysia Approves CanSino + J&J COVID-19 Vaccines!

On 15 June 2021, the Malaysia Ministry of Health (KKM) announced that both the CanSino and Johnson & Johnson vaccines against COVID1-9 received conditional approval :

  1. Convidecia Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)
    Registrant : Solution Biologics Sdn. Bhd.
    Manufacturer : CanSino Biologics Inc, China
  2. Janssen COVID-19 Vaccine
    Registrant : None (under COVAX Facility)
    Manufacturer : NA

Interestingly, both of these are single dose vaccines, which should make for easier and faster COVID-19 vaccinations.


CanSino + J&J COVID-19 Vaccines : A Quick Primer

The CanSino Convidecia vaccine works similarly to other viral vector vaccines, like the AstraZeneca AZD1222 and Gamaleya Sputnik V vaccines.

It uses a modified Ad5 virus containing the DNA instructions for the SARS-CoV-2 protein spike, which are then created by your own cells and presented on their surfaces.

These “foreign” protein spikes triggers the body’s immune system, which then makes antigens to target these spikes.

Recommended : CanSino COVID-19 Vaccine : What You Need To Know!

The Johnson & Johnson Janssen COVID-19 vaccine is similar to the CanSino Convidecia vaccine, except it uses a modified Ad26 virus to carry the DNA instructions for the SARS-CoV-2 protein spike.

Once injected, the DNA instructions are used to manufacture the SARS-CoV-2 spike protein, which is presented on the cell surface to trigger our immune system.

The antibodies they create will attack the real SARS-CoV-2 virus, which would prevent or mitigate an infection.


Recommended Reading


Support Us!

If you like our work, you can support us by visiting our sponsors, or even donating to our fund. Any help you can render is greatly appreciated!

Exit mobile version